124 related articles for article (PubMed ID: 19122208)
1. Repression of estrogen receptor alpha by CDK11p58 through promoting its ubiquitin-proteasome degradation.
Wang Y; Zong H; Chi Y; Hong Y; Yang Y; Zou W; Yun X; Gu J
J Biochem; 2009 Mar; 145(3):331-43. PubMed ID: 19122208
[TBL] [Abstract][Full Text] [Related]
2. CDK11p58 represses vitamin D receptor-mediated transcriptional activation through promoting its ubiquitin-proteasome degradation.
Chi Y; Hong Y; Zong H; Wang Y; Zou W; Yang J; Kong X; Yun X; Gu J
Biochem Biophys Res Commun; 2009 Aug; 386(3):493-8. PubMed ID: 19538938
[TBL] [Abstract][Full Text] [Related]
3. CDK11p58 inhibits ERα-positive breast cancer invasion by targeting integrin β3 via the repression of ERα signaling.
Chi Y; Huang S; Wang L; Zhou R; Wang L; Xiao X; Li D; Cai Y; Zhou X; Wu J
BMC Cancer; 2014 Aug; 14():577. PubMed ID: 25106495
[TBL] [Abstract][Full Text] [Related]
4. Human phosphatidylethanolamine-binding protein 4 promotes transactivation of estrogen receptor alpha (ERalpha) in human cancer cells by inhibiting proteasome-dependent ERalpha degradation via association with Src.
Liu H; Qiu J; Li N; Chen T; Cao X
J Biol Chem; 2010 Jul; 285(29):21934-42. PubMed ID: 20460377
[TBL] [Abstract][Full Text] [Related]
5. CHIP (carboxyl terminus of Hsc70-interacting protein) promotes basal and geldanamycin-induced degradation of estrogen receptor-alpha.
Fan M; Park A; Nephew KP
Mol Endocrinol; 2005 Dec; 19(12):2901-14. PubMed ID: 16037132
[TBL] [Abstract][Full Text] [Related]
6. Ligand-dependent switching of ubiquitin-proteasome pathways for estrogen receptor.
Tateishi Y; Kawabe Y; Chiba T; Murata S; Ichikawa K; Murayama A; Tanaka K; Baba T; Kato S; Yanagisawa J
EMBO J; 2004 Dec; 23(24):4813-23. PubMed ID: 15538384
[TBL] [Abstract][Full Text] [Related]
7. The GPER1/SPOP axis mediates ubiquitination-dependent degradation of ERα to inhibit the growth of breast cancer induced by oestrogen.
Zhang N; Sun P; Xu Y; Li H; Liu H; Wang L; Cao Y; Zhou K; TinghuaiWang
Cancer Lett; 2021 Feb; 498():54-69. PubMed ID: 33069770
[TBL] [Abstract][Full Text] [Related]
8. Estrogen receptor-alpha hinge-region lysines 302 and 303 regulate receptor degradation by the proteasome.
Berry NB; Fan M; Nephew KP
Mol Endocrinol; 2008 Jul; 22(7):1535-51. PubMed ID: 18388150
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of CDK11p58 and cyclin D3 following spinal cord injury in rats.
Ji Y; Xiao F; Sun L; Qin J; Shi S; Yang J; Liu Y; Zhou D; Zhao J; Shen A
Mol Cell Biochem; 2008 Feb; 309(1-2):49-60. PubMed ID: 18008145
[TBL] [Abstract][Full Text] [Related]
10. Clomiphene citrate down-regulates estrogen receptor-α through the ubiquitin-proteasome pathway in a human endometrial cancer cell line.
Amita M; Takahashi T; Igarashi H; Nagase S
Mol Cell Endocrinol; 2016 Jun; 428():142-7. PubMed ID: 27033325
[TBL] [Abstract][Full Text] [Related]
11. The aryl hydrocarbon receptor mediates degradation of estrogen receptor alpha through activation of proteasomes.
Wormke M; Stoner M; Saville B; Walker K; Abdelrahim M; Burghardt R; Safe S
Mol Cell Biol; 2003 Mar; 23(6):1843-55. PubMed ID: 12612060
[TBL] [Abstract][Full Text] [Related]
12. Glycogen synthase kinase-3 protects estrogen receptor alpha from proteasomal degradation and is required for full transcriptional activity of the receptor.
Grisouard J; Medunjanin S; Hermani A; Shukla A; Mayer D
Mol Endocrinol; 2007 Oct; 21(10):2427-39. PubMed ID: 17609434
[TBL] [Abstract][Full Text] [Related]
13. Identification of an estrogen receptor α non covalent ubiquitin-binding surface: role in 17β-estradiol-induced transcriptional activity.
Pesiri V; La Rosa P; Stano P; Acconcia F
J Cell Sci; 2013 Jun; 126(Pt 12):2577-82. PubMed ID: 23591816
[TBL] [Abstract][Full Text] [Related]
14. Janus kinase 2--a novel negative regulator of estrogen receptor α function.
Gupta N; Grebhardt S; Mayer D
Cell Signal; 2012 Jan; 24(1):151-61. PubMed ID: 21907792
[TBL] [Abstract][Full Text] [Related]
15. Involvement of suppressor for Gal 1 in the ubiquitin/proteasome-mediated degradation of estrogen receptors.
Masuyama H; Hiramatsu Y
J Biol Chem; 2004 Mar; 279(13):12020-6. PubMed ID: 14702340
[TBL] [Abstract][Full Text] [Related]
16. Cyclin D3/CDK11(p58) complex involved in Schwann cells proliferation repression caused by lipopolysaccharide.
Duan Y; He X; Yang H; Ji Y; Tao T; Chen J; Hu L; Zhang F; Li X; Wang H; Shen A; Lu X
Inflammation; 2010 Jun; 33(3):189-99. PubMed ID: 20066559
[TBL] [Abstract][Full Text] [Related]
17. The breast cell growth inhibitor, estrogen down regulated gene 1, modulates a novel functional interaction between estrogen receptor alpha and transcriptional elongation factor cyclin T1.
Wittmann BM; Fujinaga K; Deng H; Ogba N; Montano MM
Oncogene; 2005 Aug; 24(36):5576-88. PubMed ID: 15940264
[TBL] [Abstract][Full Text] [Related]
18. The NEDD8 pathway is required for proteasome-mediated degradation of human estrogen receptor (ER)-alpha and essential for the antiproliferative activity of ICI 182,780 in ERalpha-positive breast cancer cells.
Fan M; Bigsby RM; Nephew KP
Mol Endocrinol; 2003 Mar; 17(3):356-65. PubMed ID: 12554766
[TBL] [Abstract][Full Text] [Related]
19. CSN5/Jab1 is involved in ligand-dependent degradation of estrogen receptor {alpha} by the proteasome.
Calligé M; Kieffer I; Richard-Foy H
Mol Cell Biol; 2005 Jun; 25(11):4349-58. PubMed ID: 15899841
[TBL] [Abstract][Full Text] [Related]
20. CDK11p58 phosphorylation of PAK1 Ser174 promotes DLC2 binding and roles on cell cycle progression.
Kong X; Gan H; Hao Y; Cheng C; Jiang J; Hong Y; Yang J; Zhu H; Chi Y; Yun X; Gu J
J Biochem; 2009 Sep; 146(3):417-27. PubMed ID: 19520772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
